These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 31231766)
1. Six vs Eight Weeks of Antibiotics for Small Mycobacterium ulcerans Lesions in Australian Patients. O'Brien DP; Friedman ND; Cowan R; Walton A; Athan E Clin Infect Dis; 2020 Apr; 70(9):1993-1997. PubMed ID: 31231766 [TBL] [Abstract][Full Text] [Related]
2. Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease. O'Brien DP; Friedman ND; McDonald A; Callan P; Hughes A; Walton A; Athan E PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006357. PubMed ID: 29554101 [TBL] [Abstract][Full Text] [Related]
3. Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort study. O'Brien DP; McDonald A; Callan P; Robson M; Friedman ND; Hughes A; Holten I; Walton A; Athan E PLoS Negl Trop Dis; 2012 Jan; 6(1):e1473. PubMed ID: 22272368 [TBL] [Abstract][Full Text] [Related]
4. Increasing Experience with Primary Oral Medical Therapy for Mycobacterium ulcerans Disease in an Australian Cohort. Friedman ND; Athan E; Walton AL; O'Brien DP Antimicrob Agents Chemother; 2016 May; 60(5):2692-5. PubMed ID: 26883709 [TBL] [Abstract][Full Text] [Related]